Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-2-15
|
pubmed:abstractText |
The aim of this study was to investigate the protective action of a new compound, ranitidine bismuth citrate, in the prevention of aspirin-induced acute mucosal injury to the upper gastrointestinal tract of healthy human volunteers. In a double-blind randomized three-way cross-over study 24 male volunteers received placebo, 900 mg aspirin or 900 mg aspirin and 800 mg ranitidine bismuth citrate at 12-h intervals for nine doses with a 2-week wash-out period between each treatment. The median (interquartile range) number of erosions seen at endoscopy when ranitidine bismuth citrate was given with aspirin (1 [0-4]) was significantly lower than aspirin alone (24 [16-32]) (P < 0.001) and not significantly different from either baseline or placebo (0 [0-2]). These findings were similarly reflected in the effects on microbleeding following the ninth dose: 12.1 (7.1-21.0) microL/10 min following aspirin alone compared to levels with placebo of 1.2 (0.4-2.9), and with aspirin and ranitidine bismuth citrate of 1.6 (0.8-2.6) (P < 0.005). Ranitidine bismuth citrate conferred substantial protection from aspirin-induced injury to the gastric and duodenal mucosa as determined by both endoscopic assessment and microbleeding rates, reducing injury to placebo levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Bismuth,
http://linkedlifedata.com/resource/pubmed/chemical/Citrates,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H2 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Ranitidine,
http://linkedlifedata.com/resource/pubmed/chemical/ranitidine bismuth citrate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0269-2813
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
515-21
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7904188-Adult,
pubmed-meshheading:7904188-Aspirin,
pubmed-meshheading:7904188-Bismuth,
pubmed-meshheading:7904188-Citrates,
pubmed-meshheading:7904188-Double-Blind Method,
pubmed-meshheading:7904188-Duodenum,
pubmed-meshheading:7904188-Gastric Mucosa,
pubmed-meshheading:7904188-Gastrointestinal Hemorrhage,
pubmed-meshheading:7904188-Histamine H2 Antagonists,
pubmed-meshheading:7904188-Humans,
pubmed-meshheading:7904188-Hydrogen-Ion Concentration,
pubmed-meshheading:7904188-Male,
pubmed-meshheading:7904188-Ranitidine
|
pubmed:year |
1993
|
pubmed:articleTitle |
Ranitidine bismuth citrate and aspirin-induced gastric mucosal injury.
|
pubmed:affiliation |
Department of Therapeutics, University Hospital, Nottingham, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|